Weill Medical College of Cornell University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

417

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

11 drugs in development

Phase 32

Phase 27

Phase 15

By Therapeutic Area

top 4

Oncology

646%

Neurology

18%

Gastroenterology

18%

Musculoskeletal

18%

R&D Momentum

89/100

Pipeline Velocity

65/100

Trial Completion Rate

57/100

Pipeline Concentration

33/100

Pipeline Freshness

61/100

Strategic Signals

↗Active in Neurology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Sep 18, 2026

Active, not recruiting

A Seamless Phase 2A-Phase 2B Randomized Double-Blind Placebo- Controlled Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

Sep 18, 2026

Recruiting

CONNECT-HTN Trial - Coaching and Navigation by CHWs Through Telehealth for High-risk Hypertension

Sep 17, 2026

Recruiting

Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers

Sep 17, 2026

Recruiting

A Pilot Study on Tolerance and Ease of Implementation of Intensive Visual Stimulation (IVS3) in Daily Practice for Upper Limb Motor Recovery in Outpatient Rehab Center

Sep 16, 2026

Recruiting

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation (MINUTE) Trial

Sep 15, 2026

Completed

Phase I/ll Dose-escalation Study of Fractionated Dose 177Lu-PSMA-617 for Progressive Metastatic Castration Resistant Prostate Cancer

Sep 15, 2026

Active, not recruiting

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

Sep 9, 2026

Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

Sep 9, 2026

Recruiting

Outcomes of a Digital Mindfulness Meditation App-Based Intervention in Adolescents With Moderate to Severe Atopic Dermatitis (MIND-AD)

Sep 9, 2026

Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

1 more events

Sep 1, 2026TrialSSTR2-Targeted PET Imaging of Meningioma: Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

TaxolPhase 2

Follicular Lymphoma

Tazemetostat PillPhase 2

Gastric Adenocarcinoma

OBP-301Phase 2

Non-Small Cell Lung Carcinoma

TVB-2640Phase 2

Prostate Cancer

Fractionated dose of 225Ac-J591Phase 1

TVB-2640Phase 1

Unknown / Other

Anal Fistula

E-CEL UVECPhase 1

Gut Microbiome

L-Phenylalanine VegPhase 3

Labor

Standard BupivacainePhase 3

Richter's Transformation

HydroxydaunomycinPhase 2

Showing 15 of 17 programs

Regulatory